vs
AdvanSix Inc.（ASIX）与杜邦（DD）财务数据对比。点击上方公司名可切换其他公司
杜邦净利率更高（4.9% vs -0.8%，领先5.7%）。AdvanSix Inc.同比增速更快（9.4% vs -182.3%）。AdvanSix Inc.自由现金流更多（$36.1M vs $-850.0M）。过去两年杜邦的营收复合增速更高（NaN% vs NaN%）
AdvanSix Inc.是一家美国化工企业，主营尼龙6以及己内酰胺、硫酸铵肥料等相关化工产品。该公司原为霍尼韦尔旗下树脂与化工事业部，于2016年分拆独立，2019年预估营收达14亿美元，其企业历史可追溯至1884年在宾夕法尼亚州法兰克福成立的H. W. Jayne公司。
杜邦（DuPont de Nemours, Inc.）是1802年由法裔美国化学家、实业家埃莱乌泰尔·伊雷内·杜邦创立的美国跨国化工企业，最初以火药供应为核心业务起家，在发展过程中对美国特拉华州的建设推进起到了重要作用，业务布局覆盖全球多个地区。
ASIX vs DD — 直观对比
营收规模更大
ASIX
是对方的-0.1倍
$-2.5B
营收增速更快
ASIX
高出191.7%
-182.3%
净利率更高
DD
高出5.7%
-0.8%
自由现金流更多
ASIX
多$886.1M
$-850.0M
两年增速更快
DD
近两年复合增速
3.4%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $359.9M | $-2.5B |
| 净利润 | $-2.8M | $-126.0M |
| 毛利率 | 7.6% | — |
| 营业利润率 | -0.7% | — |
| 净利率 | -0.8% | 4.9% |
| 营收同比 | 9.4% | -182.3% |
| 净利润同比 | -892.9% | -6.8% |
| 每股收益（稀释后） | $-0.11 | $-0.30 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASIXDD
| Q4 25 | $359.9M | $-2.5B | ||
| Q3 25 | $374.5M | $3.1B | ||
| Q2 25 | $410.0M | $3.3B | ||
| Q1 25 | $377.8M | $3.1B | ||
| Q4 24 | $329.1M | $3.1B | ||
| Q3 24 | $398.2M | $3.2B | ||
| Q2 24 | $453.5M | $3.2B | ||
| Q1 24 | $336.8M | $2.9B |
净利润ASIXDD
| Q4 25 | $-2.8M | $-126.0M | ||
| Q3 25 | $-2.6M | $-123.0M | ||
| Q2 25 | $31.4M | $59.0M | ||
| Q1 25 | $23.3M | $-589.0M | ||
| Q4 24 | $352.0K | $-118.0M | ||
| Q3 24 | $22.3M | $454.0M | ||
| Q2 24 | $38.9M | $178.0M | ||
| Q1 24 | $-17.4M | $189.0M |
毛利率ASIXDD
| Q4 25 | 7.6% | — | ||
| Q3 25 | 6.8% | 38.9% | ||
| Q2 25 | 14.3% | 37.3% | ||
| Q1 25 | 14.2% | 37.4% | ||
| Q4 24 | 3.4% | 36.4% | ||
| Q3 24 | 14.4% | 37.4% | ||
| Q2 24 | 17.9% | 37.1% | ||
| Q1 24 | 0.9% | 34.6% |
营业利润率ASIXDD
| Q4 25 | -0.7% | — | ||
| Q3 25 | -0.9% | 10.6% | ||
| Q2 25 | 7.7% | 9.4% | ||
| Q1 25 | 7.7% | -14.0% | ||
| Q4 24 | -3.9% | 1.4% | ||
| Q3 24 | 7.5% | 18.4% | ||
| Q2 24 | 11.5% | 9.3% | ||
| Q1 24 | -7.0% | 9.1% |
净利率ASIXDD
| Q4 25 | -0.8% | 4.9% | ||
| Q3 25 | -0.7% | -4.0% | ||
| Q2 25 | 7.7% | 1.8% | ||
| Q1 25 | 6.2% | -19.2% | ||
| Q4 24 | 0.1% | -3.8% | ||
| Q3 24 | 5.6% | 14.2% | ||
| Q2 24 | 8.6% | 5.6% | ||
| Q1 24 | -5.2% | 6.4% |
每股收益（稀释后）ASIXDD
| Q4 25 | $-0.11 | $-0.30 | ||
| Q3 25 | $-0.10 | $-0.29 | ||
| Q2 25 | $1.15 | $0.14 | ||
| Q1 25 | $0.86 | $-1.41 | ||
| Q4 24 | $0.02 | $-0.28 | ||
| Q3 24 | $0.82 | $1.08 | ||
| Q2 24 | $1.43 | $0.42 | ||
| Q1 24 | $-0.65 | $0.45 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $19.8M | $715.0M |
| 总债务越低越好 | — | $3.1B |
| 股东权益账面价值 | $815.2M | $13.9B |
| 总资产 | $1.7B | $21.6B |
| 负债/权益比越低杠杆越低 | — | 0.23× |
8季度趋势，按日历期对齐
现金及短期投资ASIXDD
| Q4 25 | $19.8M | $715.0M | ||
| Q3 25 | $23.7M | $2.0B | ||
| Q2 25 | $18.4M | $1.8B | ||
| Q1 25 | $8.3M | $1.8B | ||
| Q4 24 | $19.6M | $1.9B | ||
| Q3 24 | $17.3M | $1.6B | ||
| Q2 24 | $12.1M | $1.5B | ||
| Q1 24 | $20.6M | $1.9B |
总债务ASIXDD
| Q4 25 | — | $3.1B | ||
| Q3 25 | — | $7.0B | ||
| Q2 25 | — | $5.3B | ||
| Q1 25 | — | $5.3B | ||
| Q4 24 | — | $5.3B | ||
| Q3 24 | — | $7.2B | ||
| Q2 24 | — | $7.2B | ||
| Q1 24 | — | $7.8B |
股东权益ASIXDD
| Q4 25 | $815.2M | $13.9B | ||
| Q3 25 | $818.2M | $22.9B | ||
| Q2 25 | $823.7M | $23.1B | ||
| Q1 25 | $794.4M | $22.8B | ||
| Q4 24 | $774.6M | $23.4B | ||
| Q3 24 | $766.4M | $24.2B | ||
| Q2 24 | $746.6M | $23.3B | ||
| Q1 24 | $713.2M | $23.6B |
总资产ASIXDD
| Q4 25 | $1.7B | $21.6B | ||
| Q3 25 | $1.7B | $38.0B | ||
| Q2 25 | $1.6B | $36.6B | ||
| Q1 25 | $1.6B | $36.0B | ||
| Q4 24 | $1.6B | $36.6B | ||
| Q3 24 | $1.5B | $37.5B | ||
| Q2 24 | $1.5B | $36.6B | ||
| Q1 24 | $1.5B | $37.7B |
负债/权益比ASIXDD
| Q4 25 | — | 0.23× | ||
| Q3 25 | — | 0.31× | ||
| Q2 25 | — | 0.23× | ||
| Q1 25 | — | 0.23× | ||
| Q4 24 | — | 0.23× | ||
| Q3 24 | — | 0.30× | ||
| Q2 24 | — | 0.31× | ||
| Q1 24 | — | 0.33× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $63.7M | $-700.0M |
| 自由现金流经营现金流 - 资本支出 | $36.1M | $-850.0M |
| 自由现金流率自由现金流/营收 | 10.0% | 33.4% |
| 资本支出强度资本支出/营收 | 7.7% | -5.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $6.4M | $-73.0M |
8季度趋势，按日历期对齐
经营现金流ASIXDD
| Q4 25 | $63.7M | $-700.0M | ||
| Q3 25 | $26.6M | $497.0M | ||
| Q2 25 | $21.1M | $381.0M | ||
| Q1 25 | $11.4M | $382.0M | ||
| Q4 24 | $64.2M | $564.0M | ||
| Q3 24 | $57.3M | $737.0M | ||
| Q2 24 | $50.2M | $527.0M | ||
| Q1 24 | $-36.2M | $493.0M |
自由现金流ASIXDD
| Q4 25 | $36.1M | $-850.0M | ||
| Q3 25 | $66.0K | $379.0M | ||
| Q2 25 | $-7.2M | $265.0M | ||
| Q1 25 | $-22.6M | $133.0M | ||
| Q4 24 | $29.8M | $403.0M | ||
| Q3 24 | $26.8M | $628.0M | ||
| Q2 24 | $16.7M | $425.0M | ||
| Q1 24 | $-71.6M | $286.0M |
自由现金流率ASIXDD
| Q4 25 | 10.0% | 33.4% | ||
| Q3 25 | 0.0% | 12.3% | ||
| Q2 25 | -1.7% | 8.1% | ||
| Q1 25 | -6.0% | 4.3% | ||
| Q4 24 | 9.1% | 13.0% | ||
| Q3 24 | 6.7% | 19.7% | ||
| Q2 24 | 3.7% | 13.4% | ||
| Q1 24 | -21.3% | 9.8% |
资本支出强度ASIXDD
| Q4 25 | 7.7% | -5.9% | ||
| Q3 25 | 7.1% | 3.8% | ||
| Q2 25 | 6.9% | 3.6% | ||
| Q1 25 | 9.0% | 8.1% | ||
| Q4 24 | 10.4% | 5.2% | ||
| Q3 24 | 7.7% | 3.4% | ||
| Q2 24 | 7.4% | 3.2% | ||
| Q1 24 | 10.5% | 7.1% |
现金转化率ASIXDD
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.67× | 6.46× | ||
| Q1 25 | 0.49× | — | ||
| Q4 24 | 182.29× | — | ||
| Q3 24 | 2.57× | 1.62× | ||
| Q2 24 | 1.29× | 2.96× | ||
| Q1 24 | — | 2.61× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
DD
暂无分部数据
